AR and prostate carcinoma: In the same study, over-expression of cyclin D2 induced anti-proliferative effects on LnCap cells, but not PC3 cells, suggesting that the inhibitory effects of cyclin D2 is limited to AR-dependent prostate cancer cells [30].